GOLPH3 and ductal breast carcinoma in situ: Compared with FAP-a and GOLPH3, the combination of FAP-a and GOLPH3 refined the specificity and sensitivity of potent prediction of DCIS recurrence by 9.72–10.31 and 2.72–3.63%, respectively.